There are 29 resources available
Participants clinical case discussion: Salvage treatment for isolated lymph node recurrence
Presenter: I. González Ginel, ES
Session: Session 2 - Biochemical relapse
Resources:
Slides
Webcast
ADT and other hormonal treatments, mechanisms of action, main efficacy results and toxicities
Presenter: S. Gillessen, CH
Session: Session 3 - Systemic treatment options and molecular characterisation
Resources:
Slides
Webcast
Chemotherapy (taxanes and platins) and Radium-223, mechanism of action, main efficacy results in Castration-Resistant Prostate Cancer (CRPC) and toxicities
Presenter: E. Castro, ES
Session: Session 3 - Systemic treatment options and molecular characterisation
Resources:
Slides
Webcast
Bone health agents, mechanism of action, efficacy and toxicities
Presenter: G. Baciarello, IT
Session: Session 3 - Systemic treatment options and molecular characterisation
Resources:
Slides
Webcast
Molecular characterisation: Germline and somatic testing
Presenter: E. Castro, ES
Session: Session 3 - Systemic treatment options and molecular characterisation
Resources:
Slides
Webcast
Participants clinical case discussion: The role of precision medicine in metastatic prostate cancer: Liquid biopsy may help to personalize treatment
Presenter: J. Gavira Diaz, FR
Session: Session 3 - Systemic treatment options and molecular characterisation
Resources:
Slides
Webcast
Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Presenter: S. Gillessen, CH
Session: Session 4 - Castration-sensitive metastatic prostate cancer
Resources:
Slides
Webcast
Triplet and quadruplet options (mCSPC)
Presenter: K. Fizazi, FR
Session: Session 4 - Castration-sensitive metastatic prostate cancer
Resources:
Slides
Webcast
Monitoring of mCSPC
Presenter: K. Herrmann, DE
Session: Session 4 - Castration-sensitive metastatic prostate cancer
Resources:
Slides
Webcast
Oligo-metastatic disease: What treatment?
Presenter: T. Zilli, CH
Session: Session 4 - Castration-sensitive metastatic prostate cancer
Resources:
Slides
Webcast